Edit search
Blocking of interleukin-17 during reactivation of experiment…
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
Article, Chapter
Authors: M.I. Koenders
Publication: American Journal of Pathology, The, Volume:167, Issue:1, Page(s):141
Published: Elsevier, 2005
ISSN: 0002-9440
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item